Objective To understand ocular manifestations of patients with cerebral venous sinus stenosis
(CVSS), analyze fundus changes after venous sinus stenting and explore possible related factors of
papilledema degree.
Methods Data of patients with CVSS in Neurointervention Center, Beijng Tian Tan Hospital from
January 2014 to August 2018 were retrospectively analyzed. The ocular characteristics of CVSS
patients and ophthalmological changes after CVSS stenting were analyzed and summarized.
Results Of 125 patients, 101 (80.8%) had visual impairment, including blurred vision or decreased
vision, metamorphosis, transient amaurosis, visual field defect, diplopia. 65 (52.0%) patients had
ocular discomfort as the first symptom and 35 (28.0%) patients had only ocular symptom. Of 115
patients (223 eyes) with initial papilledema, the median pepilledema grade was 3 (2-4) (Frisén grades). Some patients showed hemorrhage, exudation, cotton-wool spot, retinal tissue fold
surrounding the disc, dilated and tortuous retinal veins, papilla pale. There was a positive relevance
between papilledema grade and intracranial pressure (Kendall’s tau-b=0.271, P =0.029), and a
negative relevance between papilledema grade and duration of the disease (Kendall’s tau-b=-0.261,
P =0.002). 79 patients underwent venous sinus stenting, papilledema of all patients with stenting
alleviated soon after operation. At 1 month after stenting, the grade of papilledema was reduced
to grade 2 (1-3). At 6 months after stenting, 94.4% eyes (135/143) with initial papilledema had no
edema in the disc.
Conclusions Patients with binocular papilledema should consider CVSS. The fundus examination
is necessary for diagnosis and follow up of CVSS and assessing intracranial pressure. Papilledema
degree had a positive relevance with intracranial pressure, and a negative relevance with duration of
the disease. Patients with CVSS and papilledema who are refractory for medical treatment should
consider venous sinus stenting as possible as earlier to reduce papilledema and irreversible damage
of optic nerve.